• Duration of symptoms 10 days or more AND symptoms clearly getting better. • Residents in an aged care facility (hostel or nursing home) or quarantine hotel. • Not usually fully independent in activities of daily living and self-care including: washing, toileting, dressing and dental care. • Current residence outside logistical boundaries of the study as defined from time to time during recruitment. • Self reported severe liver disease and/or cirrhosis • Use of warfarin. • Known allergy to Ivermectin • Fit, seizure or stroke in the last 6 months. • Dementia of any type • Head injury requiring medical attention in the last 6 months • Concussion in the last 6 months • Current use of any of the following medications: verapamil, ciclosporin, cobicistat, ritonavir, ketoconazole, itraconazole, fusidic acid, erythromycin, clarithromycin. • Current use or use within the last 3 months of the medication: amiodarone • Psychosocial illness which in the opinion of the investigative team would make successful trial completion (including follow up data collection) unlikely, for example including: uncontrolled substance use, homelessness, poorly controlled mental state disorder. • Inability to communicate in English to the level necessary to provide verbal consent and phone call follow up data. • Current participation in another clinical drug trial for SARS-CoV-2.

• Duration of symptoms 10 days or more AND symptoms clearly getting better. • Residents in an aged care facility (hostel or nursing home) or quarantine hotel. • Not usually fully independent in activities of daily living and self-care including: washing, toileting, dressing and dental care. • Current residence outside logistical boundaries of the study as defined from time to time during recruitment. • Self reported severe liver disease and/or cirrhosis • Use of warfarin. • Known allergy to Ivermectin • Fit, seizure or stroke in the last 6 months. • Dementia of any type • Head injury requiring medical attention in the last 6 months • Concussion in the last 6 months • Current use of any of the following medications: verapamil, ciclosporin, cobicistat, ritonavir, ketoconazole, itraconazole, fusidic acid, erythromycin, clarithromycin. • Current use or use within the last 3 months of the medication: amiodarone • Psychosocial illness which in the opinion of the investigative team would make successful trial completion (including follow up data collection) unlikely, for example including: uncontrolled substance use, homelessness, poorly controlled mental state disorder. • Inability to communicate in English to the level necessary to provide verbal consent and phone call follow up data. • Current participation in another clinical drug trial for SARS-CoV-2.